Vitamin C (ascorbic acid)

Topical vitamin C covers L-ascorbic acid — the biologically active form — and a family of derivatives created largely to solve L-ascorbic acid’s central problem: it is unstable, badly behaved in formulation, and oxidises readily.

The biology is genuinely well established. The difficulty is everything between the biology and the bottle.

L-ascorbic acid, magnesium ascorbyl phosphate, sodium ascorbyl phosphate, ascorbyl-6-palmitate, tetrahexyldecyl ascorbate and ascorbyl glucoside are different molecules. They differ in stability, in whether they penetrate, in whether they convert to ascorbic acid once they do, and in how much finished-product evidence exists for each.^{[3, 8]L-ascorbic acid and topical vitamin C derivatives are distinct molecules with different stability, permeation, conversion and evidence.Directly tested by the source[3] Pinnell SR, Yang H, Omar M, et al. Topical L-ascorbic acid: percutaneous absorption studies. Dermatologic Surgery. 2001;27(2):137–142.Tier 3[8] Al-Niaimi F, Chiang NYZ. Topical Vitamin C and the Skin: Mechanisms of Action and Clinical Applications. Journal of Clinical and Aesthetic Dermatology. 2017;10(7):14–17.Tier 4}

A study of one tells you very little about the others. This is the single most useful thing to hold on to when a client asks whether their serum is “proper” vitamin C.

Ascorbate does two things worth knowing. It is an antioxidant, and it is an enzymatic cofactor in collagen hydroxylation— the step that lets collagen form a stable triple helix.^{[8]Ascorbate has established antioxidant activity and serves as an enzymatic cofactor in collagen biology.Directly tested by the source[8] Al-Niaimi F, Chiang NYZ. Topical Vitamin C and the Skin: Mechanisms of Action and Clinical Applications. Journal of Clinical and Aesthetic Dermatology. 2017;10(7):14–17.Tier 4}

That second role is why vitamin C is bound up with collagen in every piece of marketing you will read. It is real biochemistry. It is also a mechanism, not an outcome: being a required cofactor in a pathway does not establish that applying it to the face produces visible new collagen.

Two numbers are quoted as though they were law: vitamin C must be formulated below pH 3.5, and there is no point going above 20%.

Both come from a percutaneous absorption study, and that study was performed on pig skin. Its Methods say so plainly: L-ascorbic acid and its derivatives “were applied to pig skin”. Penetration rose as pH fell below 3.5 and as concentration rose towards 20%, above which it fell away.^{[3]The pH-below-3.5 and up-to-20% figures come from a percutaneous absorption study performed on pig skin, not human skin, and describe one L-ascorbic acid system rather than a universal formulation rule.Directly tested by the source[3] Pinnell SR, Yang H, Omar M, et al. Topical L-ascorbic acid: percutaneous absorption studies. Dermatologic Surgery. 2001;27(2):137–142.Tier 3}

This is not a reason to discard the findings — pig skin is a reasonable model for percutaneous absorption and the work is frequently cited for good reason. It is a reason to describe them accurately. They are penetration findings, in a non-human model, for one L-ascorbic acid system. A practitioner told “the science says below pH 3.5” will reasonably assume that came from human skin, and it did not.

The paper also carries a declared commercial interest: the lead author was a consultant to SkinCeuticals and a co-author was president of PhytoCeuticals. That is disclosed in the reference list below, as it is on every source here where one exists.

Derivatives are usually sold on tolerability and stability — gentler, less prone to oxidation, no low-pH sting. Those are real formulation advantages.

The question is whether they deliver ascorbic acid to the skin. The same pig-skin study tested three of them directly, and the answer was blunt: magnesium ascorbyl phosphate, ascorbyl-6-palmitate and dehydroascorbic acid did not increase skin levels of L-ascorbic acid.^{[3]In that same pig-skin study, magnesium ascorbyl phosphate, ascorbyl-6-palmitate and dehydroascorbic acid did not increase skin levels of L-ascorbic acid.Directly tested by the source[3] Pinnell SR, Yang H, Omar M, et al. Topical L-ascorbic acid: percutaneous absorption studies. Dermatologic Surgery. 2001;27(2):137–142.Tier 3}

That is one study, in one model, from 2001, and formulation science has moved. But it is a directly tested result rather than an assumption, and it should temper any confident claim that a derivative is “just as good, without the irritation”. If a supplier makes that claim, ask what finished-product evidence sits behind it.

The most-copied formulation in professional skincare is 15% L-ascorbic acid, 1% alpha-tocopherol and 0.5% ferulic acid. Ferulic acid stabilises the vitamin C and E combination and, in the original work, roughly doubled its photoprotection.^{[4, 10]The much-quoted antioxidant solution is 15% L-ascorbic acid, 1% alpha-tocopherol and 0.5% ferulic acid; its photoprotection result belongs to that specific formulation, and the doubling figure comes from pig skin.Directly tested by the source[4] Lin FH, Lin JY, Gupta RD, et al. Ferulic acid stabilizes a solution of vitamins C and E and doubles its photoprotection of skin. Journal of Investigative Dermatology. 2005;125(4):826–832.Tier 3[10] Murray JC, Burch JA, Streilein RD, Iannacchione MA, Hall RP, Pinnell SR. A topical antioxidant solution containing vitamins C and E stabilized by ferulic acid provides protection for human skin against damage caused by ultraviolet irradiation. Journal of the American Academy of Dermatology. 2008;59(3):418–425. doi:10.1016/j.jaad.2008.05.004.Tier 2}

Two things to hold alongside that. The doubling result came from pig skin, with three animals. And the senior author, Sheldon Pinnell, founded SkinCeuticals and held the patent behind the tested formulation — whose photoprotection figure went on to become that brand’s headline marketing claim.

A later study did test the solution on human skin and reported protection against UV damage, though the authors noted the number of patients was relatively small. That human paper is where the 0.5% figure is actually stated, which is why this entry cites it there rather than repeating the number from a study that does not contain it.

None of this makes the formula bad — it is well-reasoned chemistry with real supporting work. It means the evidence belongs to that formulation at those concentrations, and cannot be claimed by every product whose ingredient list happens to contain the same three names.

An SPF number is not a property of an ingredient. It is generated by a standardised test performed on a finished product. No vitamin C formulation in the sources reviewed here was tested for, or assigned, an SPF.^{[no source found]An SPF value is generated by a standardised test method on a finished product; no vitamin C formulation in these sources was tested for or assigned an SPF.We looked and found no source either way}

Antioxidants work on a different part of the problem — mopping up free radicals generated by radiation that has already reached the skin — rather than absorbing or reflecting it. Useful alongside sunscreen. Never instead of it, and never described to a client as “extra SPF”.

L-ascorbic acid oxidises. Everyone knows the serum goes yellow, then orange, then brown. What almost nobody can tell you is at what point it stops working.

We looked for a validated shade card — the sort of thing widely shared as “if it looks like this, bin it” — and could not find one in any source reviewed.^{[no source found]We found no validated universal colour chart telling a practitioner when a vitamin C product has oxidised enough to stop using it.We looked and found no source either way}

What can be said honestly: darkening indicates oxidation, oxidation means less active L-ascorbic acid, and a heavily discoloured product is likely to be doing less than it was. That is a reason to buy smaller volumes in air-restrictive packaging and to store them properly. It is not a validated safety threshold, and we should not pretend it is one.

The rule against layering vitamin C with niacinamide traces to a 1968 analytical-chemistry paper that ran polarography on the two molecules in water and saw a coloured complex form. There was no skin, no finished product, no efficacy endpoint and no harm endpoint — and the concentrations used were roughly ten times below typical cosmetic levels, not above them.^{[9]The rule against layering vitamin C with niacinamide rests on 1968 test-tube polarography at concentrations below cosmetic use levels, with no skin and no finished product.Directly tested by the source[9] Okazaki Y, Otsuki T, Miyasaka K, Nabikawa T. The behaviors of nicotinamide–ascorbic acid complex. Polarographic studies of charge-transfer complexes. Bunseki Kagaku. 1968;17(10):1228–1232.Tier 3}

One further thing to keep straight, because the debunk usually scrambles it too. The folklore fuses two different laboratory questions: mid-century solution studies of how nicotinamide and ascorbic acid associate with one another, and a separate literature on niacinamide hydrolysing to niacin under heat— work that did not involve vitamin C at all. Only the first is registered here, because it is the one we read. Neither tests a modern finished cosmetic on human skin.

There is no good evidence that layering modern finished products of each is ineffective or harmful. If a specific pairing stings a specific client, treat that as tolerance and formulation, not chemistry.

This is the part the marketing skips. A systematic review of topical vitamin C for wrinkles gathered 139 volunteers across seven publications— and found that every one of the seven was confounded, either by combination formulations or by concurrent procedures. No wrinkle effect can be cleanly attributed to vitamin C on its own.^{[1, 2]Clinical evidence for topical vitamin C in pigmentation and photoageing is promising but small and heterogeneous; across 139 volunteers in 7 wrinkle publications, every study was confounded by combination formulas or concurrent procedures.Directly tested by the source[1] Correia G, Magina S. Efficacy of topical vitamin C in melasma and photoaging: A systematic review. Journal of Cosmetic Dermatology. 2023;22(7):1938–1945. doi:10.1111/jocd.15748.Tier 1[2] Sanabria B, Berger LE, Mohd H, et al. Clinical Efficacy of Topical Vitamin C on the Appearance of Wrinkles: A Systematic Literature Review. Journal of Drugs in Dermatology. 2023;22(9):898–904. doi:10.36849/JDD.7332.Tier 1}

The better individual studies are real but modest, and they are studies of products. One is a six-month double-blind randomised paired trial of a 5% cream against its own excipient on photoaged low-neck and arm skin, favouring the active side on investigator and self-assessment. The other — the one most often quoted as “the vitamin C study” — is a three-month randomised, double-blind, vehicle-controlled split-face trial of one named branded serum in nineteen evaluable people aged 36 to 72, all Fitzpatrick I to III, reporting 73.7% improvement in profilometry roughness and shadows.^{[5, 6]A six-month double-blind randomised paired trial of a 5% cream against its own excipient on photoaged low-neck and arm skin favoured the active side. Separately, a three-month randomised, double-blind, vehicle-controlled split-face study of ONE NAMED BRANDED SERUM (Cellex-C high-potency) in NINETEEN evaluable participants aged 36 to 72, all Fitzpatrick I to III, reported 73.7% improvement in optical-profilometry roughness and shadows, 84.2% on patient questionnaires and 57.9% on photographic assessment. Both are formulation-specific results in small, selected groups — not evidence about topical vitamin C as a category.Directly tested by the source[5] Humbert PG, Haftek M, Creidi P, et al. Topical ascorbic acid on photoaged skin. Clinical, topographical and ultrastructural evaluation: double-blind study vs. placebo. Experimental Dermatology. 2003;12(3):237–244.Tier 2[6] Traikovich SS. Use of topical ascorbic acid and its effects on photodamaged skin topography. Archives of Otolaryngology–Head & Neck Surgery. 1999;125(10):1091–1098.Tier 2}

Nineteen people, three phototypes, one formulation. It is a reasonable result for that serum. It is not a result about the ingredient, and it certainly is not one about whatever vitamin C product you happen to retail.

For pigmentation and melasma the picture is similar — promising, small, heterogeneous, and not a basis for promising a client clearance.

• Ask which molecule.“Contains vitamin C” on a label is not information.
• Ask for finished-product evidence, not ingredient evidence. The two are routinely conflated.
• Position it as morning-side antioxidant support alongside sunscreen, not as sun protection.
• Packaging matters more than the percentage. An elegantly stabilised 10% in opaque, air-restrictive packaging will outperform an oxidised 20% in a dropper bottle.
• Set expectations at “supports”, not “builds collagen”. The cofactor role is real; the visible-collagen promise is not evidenced.

• Whether the pig-skin penetration findings translate quantitatively to human skin.
• Whether any derivative reliably raises human skin ascorbic acid to a meaningful level.
• How much of the C + E + ferulic result is ferulic acid stabilisation and how much is the vitamin C and E themselves.
• At what point oxidation makes a product clinically useless.
• Whether topical vitamin C produces any durable collagen change in human skin, as opposed to occupying a required step in the pathway.

“Vitamin C must be below pH 3.5 and under 20%.”

“Derivatives work just as well without the irritation.”

“Any C + E + ferulic serum gives you the same result.”

“It adds sun protection.”

“Vitamin C builds collagen.”

Should a client throw the serum away when it turns orange?

L-ascorbic acid or a derivative?

Can it be used with retinoids?

With niacinamide?

Why is so much of the foundational research linked to one brand?

Each source is graded by evidence tier. Tier 4 material (manufacturer documents, expert consensus, practitioner experience) is useful for protocol and context, and is never presented as equivalent to independent clinical evidence.

1. Correia G, Magina S. Efficacy of topical vitamin C in melasma and photoaging: A systematic review. Journal of Cosmetic Dermatology. 2023;22(7):1938–1945. doi:10.1111/jocd.15748.Tier 1Supports: The pigmentation and photoageing evidence base. NOTE: full text paywalled; cited at abstract level only.
2. Sanabria B, Berger LE, Mohd H, et al. Clinical Efficacy of Topical Vitamin C on the Appearance of Wrinkles: A Systematic Literature Review. Journal of Drugs in Dermatology. 2023;22(9):898–904. doi:10.36849/JDD.7332.Tier 1Supports: 139 volunteers across 7 publications. Every one of the seven wrinkle studies was confounded — by combination formulas or concurrent procedures — so no wrinkle effect can be attributed to vitamin C alone. This is an attribution-failure finding, not evidence of benefit.
3. Pinnell SR, Yang H, Omar M, et al. Topical L-ascorbic acid: percutaneous absorption studies. Dermatologic Surgery. 2001;27(2):137–142.Animal studyTier 3Supports: PIG SKIN. Penetration rose as pH fell below 3.5 and as concentration rose to 20%, above which it fell. Also directly tested three derivatives: magnesium ascorbyl phosphate, ascorbyl-6-palmitate and dehydroascorbic acid 'did not increase skin levels of L-ascorbic acid'.Funding / interest: Lead author was a consultant to SkinCeuticals; a co-author was president of PhytoCeuticals.
4. Lin FH, Lin JY, Gupta RD, et al. Ferulic acid stabilizes a solution of vitamins C and E and doubles its photoprotection of skin. Journal of Investigative Dermatology. 2005;125(4):826–832.Animal studyTier 3Supports: PIG SKIN, n=3. Ferulic acid stabilised a vitamin C and E solution and roughly doubled its photoprotection in that model.Funding / interest: Senior author Sheldon Pinnell founded SkinCeuticals and held the patent behind the tested formulation, whose photoprotection figure is that brand's headline marketing claim.
5. Humbert PG, Haftek M, Creidi P, et al. Topical ascorbic acid on photoaged skin. Clinical, topographical and ultrastructural evaluation: double-blind study vs. placebo. Experimental Dermatology. 2003;12(3):237–244.Tier 2Supports: A six-month double-blind randomised paired trial in healthy female volunteers, comparing a 5% vitamin C cream against its own excipient on photoaged low-neck and arm skin. Investigator and self-assessment both favoured the active side, with ultrastructural changes reported.
6. Traikovich SS. Use of topical ascorbic acid and its effects on photodamaged skin topography. Archives of Otolaryngology–Head & Neck Surgery. 1999;125(10):1091–1098.Tier 2Supports: A three-month randomised, double-blind, vehicle-controlled split-face study of a NAMED BRANDED PRODUCT — Cellex-C high-potency serum, Cellex-C International, Toronto — with three drops (0.5 mL) applied daily to each side of the face. NINETEEN EVALUABLE participants, aged 36 to 72, Fitzpatrick skin types I, II and III. Results: 73.7% improvement in Ra and shadows on optical profilometry, 84.2% on patient questionnaires and 57.9% on photographic assessment. SCOPE LIMIT: one named formulation, nineteen people, three phototypes. It is not evidence about topical vitamin C as a category.
7. Al-Niaimi F, Chiang NYZ. Topical Vitamin C and the Skin: Mechanisms of Action and Clinical Applications. Journal of Clinical and Aesthetic Dermatology. 2017;10(7):14–17.Tier 4Supports: Ascorbate's antioxidant activity and its role as an enzymatic cofactor in collagen hydroxylation. Also restates the pH-below-3.5 and 10–20% formulation conventions.
8. Okazaki Y, Otsuki T, Miyasaka K, Nabikawa T. The behaviors of nicotinamide–ascorbic acid complex. Polarographic studies of charge-transfer complexes. Bunseki Kagaku. 1968;17(10):1228–1232.In vitroTier 3Supports: Polarography in aqueous solution at 0.05 M each — roughly 0.9% ascorbic acid and 0.6% niacinamide, BELOW cosmetic use levels. No skin, no finished product, no efficacy or harm endpoint.
9. Murray JC, Burch JA, Streilein RD, Iannacchione MA, Hall RP, Pinnell SR. A topical antioxidant solution containing vitamins C and E stabilized by ferulic acid provides protection for human skin against damage caused by ultraviolet irradiation. Journal of the American Academy of Dermatology. 2008;59(3):418–425. doi:10.1016/j.jaad.2008.05.004.Tier 2Supports: HUMAN skin. States the tested composition explicitly: 15% L-ascorbic acid, 1% alpha-tocopherol and 0.5% ferulic acid. The authors note the number of patients evaluated was relatively small.Funding / interest: Senior author Sheldon Pinnell founded SkinCeuticals and held the patent behind the tested formulation.

• Chemical peels guide

Skinipedia is written by the educators at MSTA, the medic-led skincare training academy in Liverpool.